S&P 500   5,128.26 (+0.63%)
DOW   39,056.50 (+0.15%)
QQQ   445.05 (+1.38%)
AAPL   178.43 (-1.28%)
MSFT   414.66 (+0.25%)
META   501.55 (+2.33%)
GOOGL   138.17 (-0.21%)
AMZN   178.23 (+0.83%)
TSLA   203.69 (+0.90%)
NVDA   818.38 (+3.45%)
NIO   5.81 (+1.04%)
AMD   200.76 (+4.27%)
BABA   74.82 (+1.07%)
T   16.96 (+0.18%)
F   12.44 (+0.00%)
MU   95.68 (+5.60%)
CGC   3.26 (-0.91%)
GE   159.05 (+1.38%)
DIS   111.84 (+0.23%)
AMC   4.41 (+2.08%)
PFE   26.57 (+0.04%)
PYPL   60.65 (+0.51%)
XOM   105.71 (+1.14%)
S&P 500   5,128.26 (+0.63%)
DOW   39,056.50 (+0.15%)
QQQ   445.05 (+1.38%)
AAPL   178.43 (-1.28%)
MSFT   414.66 (+0.25%)
META   501.55 (+2.33%)
GOOGL   138.17 (-0.21%)
AMZN   178.23 (+0.83%)
TSLA   203.69 (+0.90%)
NVDA   818.38 (+3.45%)
NIO   5.81 (+1.04%)
AMD   200.76 (+4.27%)
BABA   74.82 (+1.07%)
T   16.96 (+0.18%)
F   12.44 (+0.00%)
MU   95.68 (+5.60%)
CGC   3.26 (-0.91%)
GE   159.05 (+1.38%)
DIS   111.84 (+0.23%)
AMC   4.41 (+2.08%)
PFE   26.57 (+0.04%)
PYPL   60.65 (+0.51%)
XOM   105.71 (+1.14%)
S&P 500   5,128.26 (+0.63%)
DOW   39,056.50 (+0.15%)
QQQ   445.05 (+1.38%)
AAPL   178.43 (-1.28%)
MSFT   414.66 (+0.25%)
META   501.55 (+2.33%)
GOOGL   138.17 (-0.21%)
AMZN   178.23 (+0.83%)
TSLA   203.69 (+0.90%)
NVDA   818.38 (+3.45%)
NIO   5.81 (+1.04%)
AMD   200.76 (+4.27%)
BABA   74.82 (+1.07%)
T   16.96 (+0.18%)
F   12.44 (+0.00%)
MU   95.68 (+5.60%)
CGC   3.26 (-0.91%)
GE   159.05 (+1.38%)
DIS   111.84 (+0.23%)
AMC   4.41 (+2.08%)
PFE   26.57 (+0.04%)
PYPL   60.65 (+0.51%)
XOM   105.71 (+1.14%)
S&P 500   5,128.26 (+0.63%)
DOW   39,056.50 (+0.15%)
QQQ   445.05 (+1.38%)
AAPL   178.43 (-1.28%)
MSFT   414.66 (+0.25%)
META   501.55 (+2.33%)
GOOGL   138.17 (-0.21%)
AMZN   178.23 (+0.83%)
TSLA   203.69 (+0.90%)
NVDA   818.38 (+3.45%)
NIO   5.81 (+1.04%)
AMD   200.76 (+4.27%)
BABA   74.82 (+1.07%)
T   16.96 (+0.18%)
F   12.44 (+0.00%)
MU   95.68 (+5.60%)
CGC   3.26 (-0.91%)
GE   159.05 (+1.38%)
DIS   111.84 (+0.23%)
AMC   4.41 (+2.08%)
PFE   26.57 (+0.04%)
PYPL   60.65 (+0.51%)
XOM   105.71 (+1.14%)

Silk Road Medical (SILK) Stock Price, News & Analysis

$18.04
+0.05 (+0.28%)
(As of 01:26 PM ET)
Today's Range
$17.23
$18.55
50-Day Range
$11.38
$18.25
52-Week Range
$6.08
$48.44
Volume
851,442 shs
Average Volume
904,447 shs
Market Capitalization
$702.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$25.00

Silk Road Medical MarketRank™ Stock Analysis

Analyst Rating
Hold
2.09 Rating Score
Upside/​Downside
38.6% Upside
$25.00 Price Target
Short Interest
Bearish
9.24% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.74
Upright™ Environmental Score
News Sentiment
0.72mentions of Silk Road Medical in the last 14 days
Based on 25 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.48) to ($1.37) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.33 out of 5 stars

Medical Sector

385th out of 957 stocks

Surgical & Medical Instruments Industry

46th out of 98 stocks


SILK stock logo

About Silk Road Medical Stock (NASDAQ:SILK)

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a specialty balloon for the TCAR procedure. Silk Road Medical, Inc. was incorporated in 2007 and is headquartered in Sunnyvale, California.

SILK Stock Price History

SILK Stock News Headlines

Americans Now Favor Gold Over Stocks as an Investment Vehicle
Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.
Breaking Down Silk Road Medical: 5 Analysts Share Their Views
Q4 2023 Silk Road Medical Inc Earnings Call
Silk Road Medical: Q4 Earnings Insights
Americans Now Favor Gold Over Stocks as an Investment Vehicle
Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.
Silk Road Medical Inc (SILK)
Silk Road Medical Q4 2023 Earnings Preview
Silk Road Medical Inc.
Silk Road Medical (SILK) Set to Announce Earnings on Wednesday
The chicest affordable hotels in London (under £200)
SILK Mar 2024 15.000 call
Silk Road Medical, Inc (SILK)
See More Headlines
Receive SILK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Today
3/01/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:SILK
Employees
414
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$25.00
High Stock Price Target
$55.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+39.0%
Consensus Rating
Hold
Rating Score (0-4)
2.09
Research Coverage
11 Analysts

Profitability

Net Income
$-55,010,000.00
Pretax Margin
-32.57%

Debt

Sales & Book Value

Annual Sales
$138.64 million
Book Value
$4.30 per share

Miscellaneous

Free Float
36,336,000
Market Cap
$700.53 million
Optionable
Optionable
Beta
1.45
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report














SILK Stock Analysis - Frequently Asked Questions

Should I buy or sell Silk Road Medical stock right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last twelve months. There are currently 2 sell ratings, 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SILK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SILK, but not buy additional shares or sell existing shares.
View SILK analyst ratings
or view top-rated stocks.

What is Silk Road Medical's stock price target for 2024?

11 Wall Street research analysts have issued 1-year target prices for Silk Road Medical's shares. Their SILK share price targets range from $8.00 to $55.00. On average, they anticipate the company's share price to reach $25.00 in the next twelve months. This suggests a possible upside of 38.6% from the stock's current price.
View analysts price targets for SILK
or view top-rated stocks among Wall Street analysts.

How have SILK shares performed in 2024?

Silk Road Medical's stock was trading at $12.27 at the beginning of the year. Since then, SILK stock has increased by 47.0% and is now trading at $18.04.
View the best growth stocks for 2024 here
.

When is Silk Road Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our SILK earnings forecast
.

How were Silk Road Medical's earnings last quarter?

Silk Road Medical, Inc (NASDAQ:SILK) posted its earnings results on Wednesday, February, 28th. The company reported ($0.33) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.40) by $0.07. The company earned $47.27 million during the quarter, compared to the consensus estimate of $42.23 million. Silk Road Medical had a negative trailing twelve-month return on equity of 36.13% and a negative net margin of 31.70%.

What ETFs hold Silk Road Medical's stock?

ETFs with the largest weight of Silk Road Medical (NASDAQ:SILK) stock in their portfolio include American Century Focused Dynamic Growth ETF (FDG).iShares U.S. Medical Devices ETF (IHI).

What guidance has Silk Road Medical issued on next quarter's earnings?

Silk Road Medical updated its FY 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $194.0 million-$198.0 million, compared to the consensus revenue estimate of $191.7 million.

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include RTX (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA).

When did Silk Road Medical IPO?

(SILK) raised $75 million in an IPO on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

Who are Silk Road Medical's major shareholders?

Silk Road Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Wasatch Advisors LP (10.40%), Vanguard Group Inc. (7.43%), Goldman Sachs Group Inc. (5.16%), Goldman Sachs Group Inc. (5.16%), Armistice Capital LLC (4.54%) and Bellevue Group AG (3.69%). Insiders that own company stock include Andrew S Davis, Andrew S Davis, Elizabeth H Weatherman, Erica J Rogers, Erica J Rogers, Jack W Lasersohn, Kevin M Klemz, Lucas W Buchanan, Marie L Jones, Richard Ruedy and Tony M Chou.
View institutional ownership trends
.

How do I buy shares of Silk Road Medical?

Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SILK) was last updated on 3/1/2024 by MarketBeat.com Staff